Investor Kingsbrook Partners Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kingsbrook Partners Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2021-02-05 13G/A ARTL / Artelo Biosciences, Inc. 800,000 800,000
2020-10-15 13G ARTL / Artelo Biosciences, Inc. 800,000
2016-02-16 13G/A MDVL / MedAvail Holdings, Inc. 225,912 160,086
2015-12-02 13G MDVL / MedAvail Holdings, Inc. 225,912
2015-02-13 13G/A CRMD / CorMedix Inc. 61,598
2014-03-05 13G CRMD / CorMedix Inc. 1,480,000
2013-02-14 13G/A ONCS / OncoSec Medical Inc
2013-02-14 13G/A NBY / NovaBay Pharmaceuticals, Inc. 25,000
2012-03-29 13G ONCS / OncoSec Medical Inc 5,300,000
2012-02-22 13G HBIS / Home Bistro Inc. 1,613,362
2012-02-13 13G/A NBY / NovaBay Pharmaceuticals, Inc. 2,272,551
2012-02-13 13G/A 144,201